Treatment of cervical esophageal carcinoma: systematic review and meta-analysis

Treatment of cervical esophageal carcinoma: systematic review and meta-analysis

Автор: Chichevatov D.A., Seliverstova O.M., Dmitriev S.P.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 4 т.22, 2023 года.

Бесплатный доступ

Objectives. Up to date managing a cervical esophageal carcinoma (CEC) has remained a controversial challenge. The choice of treatment is still uncertain. In the present review we attempted to assess eligibility of surgery in treatment of CEC. Material and Methods. We have enquired particular publication databases and the enquiries yielded 24 contributions matching study selection criteria such as (1) original articles published from 2000 to 2022, (2) primary tumor localization in the cervical esophagus, (3) squamous cell carcinoma,(4) available characteristics of studied groups (age, sex, T, N, M, stage), (5) detailed description of curative procedures (radiation therapy, chemotherapy, surgery), (6) information about overall survival. These publications represented two arms of 14 surgical and 17 non-surgical subgroups to analyze. Individual patient data and parameter estimates have been renewed on the basis of original Kaplan-Meier curves plotted. Results. The analysis revealed a highly heterogeneous (I2=83.76 %; 95 % CI, 71.40-92.16) random effects model. Including a surgical option into treatment of CEC did not affect 3-year overall survival (р=0.665); 46.4 % (95% CI, 37.4-55.6) vs 43.7 % (95 % CI, 35.3-51.6), respectively. Possibilities of surgical and non-surgical modalities employment were discussed. Conclusion. In treatment of CEC CRT and surgery are non-inferior to each other. These modalities are evenly associated with posterior side effects and complications, which adversely affect functional outcomes and survival. The choice of a treatment mode may depend on tumor response to induction therapy. The latter demands further investigations.

Еще

Cervical esophageal carcinoma, chemoradiation therapy, surgery

Короткий адрес: https://sciup.org/140302013

IDR: 140302013   |   DOI: 10.21294/1814-4861-2023-22-4-101-108

Список литературы Treatment of cervical esophageal carcinoma: systematic review and meta-analysis

  • Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М., 2022. 252 с. [Malignant tumors in Russia in 2021 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2022. 252 p. (in Russian)].
  • Watanabe A., Taniguchi M., Kimura Y., Kikkawa T., Hosokawa M. Larynx-preserving hybrid surgery with endoscopic laryngopharyngeal surgery and open surgery for cervical esophageal cancer invading pharynx. Dis Esophagus. 2020; 33(12): 1–9. doi: 10.1093/dote/doaa020.
  • Li C.C., Chen C.Y., Chou Y.H., Huang C.J., Ku H.Y., Chien C.R. Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study. Thorac Cancer. 2021; 12(14): 2065–71. doi: 10.1111/1759-7714.14009.
  • Chen D., Zha X., Ye D., Kang M., Zhu L., Yang M., Chen Y., Zhu K., Xia W., Wang Z., Wang Y. Patterns of care and prognostic evaluation for stage I-III upper esophageal squamous cell carcinoma: a population-based study. Ann Transl Med. 2022; 10(22): 1222. doi: 10.21037/atm-22-4577.
  • NCCN. Clinical Practice Guidelines [Internet]. Esophageal and Esophagogastric Junction Cancers. Version 5.2022 [cited 01.03.2023]. URL: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
  • Рак пищевода и кардии. Клинические рекомендации. [Internet]. URL: https://oncology-association.ru/wp-content/uploads/2021/04/kr_rakpishhevoda-i-kardii_aor_30.03.2021.pdf [cited 01.03.2023]. [Clinical Guidelines. Cancer of the esophagus and cardia [Internet]. URL: https://oncology-association.ru/wp-content/uploads/2021/04/kr_rak-pishhevodai-kardii_aor_30.03.2021.pdf [cited 01.03.2023]. (in Russian)].
  • Chen P., Zhao X., Zhou F., Song X., Hu S., Jin Y., Wang X., Han X., Fan Z., Wang R., Li B., Han W., Wang P., Li J., Wan L., Zhang L., Bao Q., Chang F., Qin Y., Chang Z., Ku J., Yang H., Yuan L., Ren J., Li X., Wang L. Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes. Cancer Biol Med. 2020; 17(1): 219–26. doi: 10.20892/j.issn.2095-3941.2019.0268.
  • Liu N., Zhou Y., Lee J.J. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021; 21(1): 111. doi: 10.1186/s12874-021-01308-8.
  • Valmasoni M., Pierobon E.S., Zanchettin G., Briscolini D., Moletta L., Ruol A., Salvador R., Merigliano S. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery. Ann Surg Oncol. 2018; 25(9): 2747–55. doi: 10.1245/s10434-018-6648-6.
  • Tong D.K., Law S., Kwong D.L., Wei W.I., Ng R.W., Wong K.H. Current management of cervical esophageal cancer. World J Surg. 2011; 35(3): 600–7. doi: 10.1007/s00268-010-0876-7.
  • Gkika E., Gauler T., Eberhardt W., Stahl M., Stuschke M., Pöttgen C. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus. 2014; 27(7): 678–84. doi: 10.1111/dote.12146.
  • Chen N.B., Qiu B., Zhang J., Qiang M.Y., Zhu Y.J., Wang B., Guo J.Y., Cai L.Z., Huang S.M., Liu M.Z., Li Q., Hu Y.H., Li Q.W., Liu H. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities. Cancer Res Treat. 2020; 52(1): 31–40. doi: 10.4143/crt.2018.624.
  • Li H.X., Liu J., Cheng Y., Liu M.N., Fang W.T., Lv C.X. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study. Dis Esophagus. 2018; 31(5): 1–6. doi: 10.1093/dote/dox144.
  • Makino T., Yamasaki M., Miyazaki Y., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Mori M., Doki Y. Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases. Ann Surg Oncol. 2016; 23(s5): 858–65. doi: 10.1245/s10434-016-5511-x.
  • Cao C.N., Luo J.W., Gao L., Xu G.Z., Yi J.L., Huang X.D., Li S.Y., Xiao J.P., Liu S.Y., Xu Z.G., Tang P.Z. Primary radiotherapy compared with primary surgery in cervical esophageal cancer. JAMA Otolaryngol Head Neck Surg. 2014; 140(10): 918–26. doi: 10.1001/jamaoto.2014.2013.
  • Saeki H., Tsutsumi S., Yukaya T., Tajiri H., Tsutsumi R., Nishimura S., Nakaji Y., Kudou K., Akiyama S., Kasagi Y., Nakashima Y., Sugiyama M., Sonoda H., Ohgaki K., Oki E., Yasumatsu R., Nakashima T., Morita M., Maehara Y. Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection. Ann Surg. 2017; 265(1): 130–6. doi: 10.1097/SLA.0000000000001599.
  • Triboulet J.P., Mariette C., Chevalier D., Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg. 2001; 136(10): 1164–70. doi: 10.1001/archsurg.136.10.1164.
  • Li X., Ai D., Chen Y., Liu Q., Deng J., Zhu H., Wang Y., Wan Y., Xie Y., Chen Y., Chen W., Fan J., Wang X., Lu X., Ying H., He X., Hu C., Zhao K. Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer? Front Oncol. 2021; 11. doi: 10.3389/fonc.2021.710245.
  • Daiko H., Hayashi R., Saikawa M., Sakuraba M., Yamazaki M., Miyazaki M., Ugumori T., Asai M., Oyama W., Ebihara S. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007; 96(2): 166–72. doi: 10.1002/jso.20795.
  • Wang W.P., Ma J., Lu Q., Han Y., Li X.F., Jiang T., Zhao J.B. Larynx-preserving limited resection with total thoracic esophagectomy and gastric pull-up reconstruction: A promising treatment for selected cervical esophageal squamous cell carcinoma. Turk J Gastroenterol. 2020; 31(12): 948–54. doi: 10.5152/tjg.2020.19757.
  • Sun F., Li X., Lei D., Jin T., Liu D., Zhao H., Yang Q., Li G., Pan X. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014; 7(9): 2771–8.
  • Sakanaka K., Ishida Y., Fujii K., Itasaka S., Miyamoto S., Horimatsu T., Muto M., Mizowaki T. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiat Oncol. 2018; 13(1): 7. doi: 10.1186/s13014-018-0957-6.
  • Du X.X., Yu R., Wang Z.F., Du D.C., Liu Q.Y., Wang R.M., Kang S.R., Yang H. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy. Bosn J Basic Med Sci. 2019; 19(2): 186–94. doi: 10.17305/bjbms.2019.3873.
  • Yamada K., Murakami M., Okamoto Y., Okuno Y., Nakajima T., Kusumi F., Takakuwa H., Matsusue S. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006; 45(8): 1120–5. doi: 10.1080/02841860600609768.
  • Huang S.H., Lockwood G., Brierley J., Cummings B., Kim J., Wong R., Bayley A., Ringash J. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys. 2008; 71(3): 735–40. doi: 10.1016/j.ijrobp.2007.10.022.
  • Dai K.Y., Yu Y.C., Leu Y.S., Chi C.W., Chan M.L., Tsai C.H., Lin H.C., Huang W.C., Chen Y.J. Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer. J Clin Med. 2020; 9(2): 387. doi: 10.3390/jcm9020387.
  • Zhang P., Xi M., Zhao L., Qiu B., Liu H., Hu Y.H., Liu M.Z. Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol. 2015; 116(2): 257–61. doi: 10.1016/j.radonc.2015.07.011.
  • Zhao L., Zhou Y., Mu Y., Chai G., Xiao F., Tan L., Lin S.H., Shi M. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer. Oncotarget. 2017; 8(13): 21852–60. doi: 10.18632/oncotarget.15665.
  • Herrmann E., Mertineit N., De Bari B., Hoeng L., Caparotti F., Leiser D., Jumeau R., Cihoric N., Jensen A.D., Aebersold D.M., Ozsahin M. Outcome of proximal esophageal cancer after definitive combined chemoradiation: a Swiss multicenter retrospective study. Radiat Oncol. 2017; 12(1): 97. doi: 10.1186/s13014-017-0834-8.
  • Nakata Y., Hanai N., Nishikawa D., Suzuki H., Koide Y., Fukuda Y., Nomura M., Kodaira T., Shimizu T., Hasegawa Y. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma. Int J Clin Oncol. 2017; 22(6): 1034–41. doi: 10.1007/s10147-017-1149-3.
Еще
Статья научная
SciUp 2024 © 2024 ©